【摘要】 目的 :观察肝素对不稳定型心绞痛 (UA)高危患者近期预后的影响。方法 :将 86例Braunwald分级积分大于 3的UA患者随机分为肝素治疗组 (n =42 )和常规治疗组 (n =44 ) ,以治疗后心绞痛发作次数、住院 4周内心脏事件发生率作为评定标准。结果 :与常规治疗组相比 ,肝素治疗组心绞痛发作≥ 1次 /d的病例数明显减少 (16 .7%对 36 8% ,P <0 .0 5 ) ,心脏事件发生率低 (2 4%对 2 0 5 % ,P <0 .0 2 5 )。结论 :肝素治疗可作为降低UA高危患者心脏事件发生率的重要保护措施更多还原

【Abstract】 Aim:To observe the effect of heparin therapy on early prognosis of high risk patients with unstable angina (UA).Methods: A total of 86 patients with UA(Braunwald score>3) were randomly divided into heparin group( n=42) and regular therapeutic group ( n=44 ).Results: The cases with the rate of angina attack≥1/d and the incidence of cardiac events of heparin group were significantly less than those of regular therapeutic group (16.7% vs 36.8% and 2.4% vs 20.5%, P<0.05 ).Conclusion: Heparin therapy can serve as an important measure for reducing cardiac events in high risk patients with UA.更多还原